Dive into a captivating episode of the Alumni Ventures' Tech Optimist podcast as Mike Collins and Matt Caspari explore three breakthroughs that could redefine our health and environment. They kick off the discussion with the promising FDA approval of a new Alzheimer’s drug, offering hope in slowing the progression of this debilitating disease. Next, they tackle the pressing issue of global warming, discussing the record-breaking heat of summer 2023 and innovative solutions aimed at combating climate change. The episode concludes with a look at a revolutionary smart antibiotic that promises efficacy without compromising the microbiome, potentially transforming medical treatments. Join Mike and Matt as they delve into these technological advancements that hold the potential to dramatically improve our world.

To Learn More:

• Alumni Ventures (AV)
• AV LinkedIn
• AV Healthtech Fund
• Tech Optimist

Speakers:

• Mike Collins - Host 
• Matt Caspari - Guest 

Chapters:

• (00:00) - Intro

Legal Disclosure:

• https://av-funds.com/tech-optimist-disclosures